BIOE · Bio Essence Corp · Executive Compensation
$0.18
-0.01 (-4.21%)
At close · Sep 8
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company also had an accumulated deficit of $9,077,623 as of June 30, 2026. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$9.79M
Shares
53.81M
Volume · Sep 8
5100
Avg daily vol (10 sessions)
6870
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Simon Shavanson | Director | Resigned | 2024-06-21 |
| William Sluss | Director | Appointed | 2024-06-21 |
| Yangyang Huang | Director | Resigned | 2024-06-21 |
| Sharon Mair | Director | Resigned | 2023-12-13 |
| William E. Sluss | Chief Financial Officer (Principal Financial Officer) | Appointed | 2023-09-07 |